Published in
Taylor and Francis Group, OncoImmunology, 12(4), p. e1049804
DOI: 10.1080/2162402x.2015.1049804
Links
- ORCID
- ORCID
- ORCID
- Taylor and Francis Group | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
Prognostic and theranostic impact of molecular subtypes and immune classifications in Renal Cell Cancer (RCC) and Colorectal Cancer (CRC)
Journal article published in 2015 by
Etienne Becht,
Nicolas A. Giraldo 
,
Benoit Beuselinck,
Sylvie Job,
Laetitia Marisa,
Yann Vano,
Stéphane Oudard,
Jessica Zucman-Rossi ,
Pierre Laurent-Puig,
Catherine Sautès-Fridman,
Aurélien de Reyniès ,
Wolf Herman Fridman
,
Benoit Beuselinck,
Sylvie Job,
Laetitia Marisa,
Yann Vano,
Stéphane Oudard,
Jessica Zucman-Rossi ,
Pierre Laurent-Puig,
Catherine Sautès-Fridman,
Aurélien de Reyniès ,
Wolf Herman Fridman
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Molecular and immune classifications powerfully predict cancer patient's survival and response to therapies. We herein describe the immune tumor microenvironment of molecular subgroups of colorectal and renal cell cancers, revealing a strong correlation between tumor subtypes and distinct immune profiles. © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC.